Enovis Corporation Common Stock Q2 2025 Earnings Recap

ENOV Q2 2025 August 8, 2025

Get alerts when ENOV reports next quarter

Enovis reported solid second-quarter performance, achieving 7% revenue growth and a strong shift towards improved margins under new CEO Damien McDonald’s leadership.

Earnings Per Share Beat

$0.79 vs $0.74 est.

+6.8% surprise

Revenue Beat

564545000 vs 538611640 est.

+4.8% surprise

Market Reaction

1-Day -2.6%

5-Day +2.87%

30-Day +6.12%

See ENOV alongside your other holdings

Add to your portfolio — free

Key Takeaways

Revenue increased to $2.2 billion, up from $1.4 billion since the spin-off, supported by successful acquisitions and organic growth.
Adjusted EBITDA margins improved from 14% to nearly 18%, reflecting operational enhancements and disciplined capital allocation strategies.
Strong demand and effective cash management led to positive cash flow, amid challenges from tariffs.
The company is prioritizing commercial execution, innovation, and operational excellence to drive future growth and enhance patient outcomes.
Continued focus on embedding financial discipline across the organization to reduce costs and improve working capital efficiency.

This summary was generated by AI from the official earnings call transcript and is provided for informational purposes only. It does not constitute financial advice. For the complete transcript and financial data, visit ENOV on AllInvestView.